No Data
No Data
Analysts Expect Bausch Health Companies Inc. (NYSE:BHC) To Breakeven Soon
TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $12
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $9
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Irhythm Technologies (IRTC) and Bausch Health Companies (BHC)
Bausch Health: Navigating Market Risks Amid Uncertain Product Acceptance
Toronto Stocks Slip; Bausch Health Shares Climb on 4Q Beat, Rosy 2025 Outlook
Wolfboy : Yes